Tsuchiyama S
Adm Radiol. 1991 Jan;10(1):22-5.
"The challenge is to balance what is good for the individual against what is in society's best interests without providing disincentives for product development." This quotation from a 1988 JAMA article by Peter Jacobson and John Rosenquist exploring contrast media issues goes beyond the usual scope of concern and also crystallizes why the low osmolar contrast agent (LOCA) controversy is so typical of the dilemmas that healthcare and society as a whole will continue to confront. The first two-thirds of this quotation presents a challenge that has been the subject of the LOCA debate for some time now: how to weigh the benefit to the individual versus the cost to society. The last third of this challenge acknowledges the importance of research and development, which has been largely ignored although it represents a vital ingredient for future healthcare improvements.
“挑战在于，在不对产品研发造成抑制因素的前提下，平衡对个人有益的因素与符合社会最佳利益的因素。”彼得·雅各布森和约翰·罗森奎斯特1988年发表于《美国医学会杂志》上一篇探讨造影剂问题的文章中的这句话，超出了通常的关注范围，也阐明了为何低渗造影剂（LOCA）争议是医疗保健及整个社会将持续面临的典型困境。这句话的前三分之二提出了一个挑战，这一挑战目前已成为低渗造影剂辩论的主题一段时间了：如何权衡对个人的益处与对社会的成本。这一挑战的最后三分之一承认了研发的重要性，尽管研发是未来医疗保健改善的关键因素，但在很大程度上一直被忽视。
